triazoles has been researched along with Muscle Weakness in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ertem, M; İleri, T; İnce, E; Pekpak, E; Uysal, Z | 1 |
Guise, TA; Harhash, AA; John, SK; Kozlow, WM; Marks, AR; Mohammad, KS; Murthy, S; Niewolna, M; Regan, JN; She, Y; Waning, DL; Wright, LE | 1 |
Bhavna, B; Kumar, K; Narayan, SK; Roopeshkumar, VR; Swaminathan, RP | 1 |
3 other study(ies) available for triazoles and Muscle Weakness
Article | Year |
---|---|
Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia.
Topics: Abdominal Pain; Adolescent; Constipation; Female; Humans; Hypertension; Muscle Weakness; Mycoses; Neuralgia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles; Vincristine | 2018 |
Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo.
Topics: Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Progression; Estradiol; Female; Humans; Imidazoles; Letrozole; Mice, Inbred BALB C; Mice, Nude; Muscle Strength; Muscle Weakness; Muscle, Skeletal; Nitriles; Osteolysis; Ovariectomy; Receptors, Estrogen; Time Factors; Triazoles; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays; Zoledronic Acid | 2017 |
Isolated cerebral aspergilloma in a young immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Edema; Female; Humans; Muscle Weakness; Pyrimidines; Seizures; Treatment Outcome; Triazoles; Voriconazole | 2009 |